logo

Stock Screener

Forex Screener

Crypto Screener

EXPO

Exponent, Inc. (EXPO)

$

71.38

-0.85 (-1.19%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

2.6187

Market cap

Market cap

3.6 Billion

Price to sales ratio

Price to sales ratio

6.5078

Debt to equity

Debt to equity

0.1878

Current ratio

Current ratio

3.1537

Income quality

Income quality

1.3400

Average inventory

Average inventory

0

ROE

ROE

0.2419



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Exponent, Inc., along with its subsidiaries, functions as a global science and engineering consulting firm. This organization is structured into two primary segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment delivers extensive services across various disciplines, including biomechanics, biomedical engineering, environmental and earth sciences, civil engineering, construction consulting, data sciences, electrical engineering, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. Meanwhile, the Environmental and Health segment focuses on chemical regulation and food safety, ecological and biological sciences, and health sciences. The company's diverse expertise encompasses approximately 90 technical disciplines designed to address the complex challenges faced by stakeholders across multiple industries, including chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, and transportation. The firm’s solid financial performance is evidenced by an income before tax ratio of 0.26 reflecting its pre-tax margin. In addition, the diluted EPS is $2.11 accounting for potential share dilution, while the organization recorded an operating income of $119,557,000.00 indicative of its earnings from core operations. The operating income ratio stands at 0.21 demonstrating the company's operational profitability margin, and the net income ratio is 0.20 reflecting the overall profitability margin of Exponent, Inc. In the financial realm, the stock is reasonably priced at $74.46 making it appealing to a broad range of investors. However, it is worth noting that the stock has a low average trading volume of 359,457.00 which indicates lower market activity. With a mid-range market capitalization of $3,604,768,518.00 the company proves to be a steady performer within its sector. Exponent, Inc. is recognized as a key player in the Consulting Services industry, contributing significantly to the overall market landscape. This organization belongs to the Industrials sector and is actively driving innovation and growth, positioning itself as a significant contributor to advancements in its field.

What is Exponent, Inc. (EXPO)'s current stock price?

The current stock price of Exponent, Inc. (EXPO) is $71.38 as of 2025-08-29. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Exponent, Inc. (EXPO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict Exponent, Inc. stock to fluctuate between $63.81 (low) and $115.75 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-29, Exponent, Inc.'s market cap is $3,604,768,518, based on 50,501,100 outstanding shares.

Compared to GE Aerospace, Exponent, Inc. has a Lower Market-Cap, indicating a difference in performance.

Exponent, Inc. pays dividends. The current dividend yield is 1.65%, with a payout of $0.30 per share.

To buy Exponent, Inc. (EXPO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for EXPO. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Exponent, Inc.'s last stock split was 2:1 on 2018-06-08.

Revenue: $558,514,000 | EPS: $2.13 | Growth: 8.67%.

Visit https://www.exponent.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $127.61 (2021-11-22) | All-time low: $63.81 (2025-08-01).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

EXPO

fool.com

Exponent (EXPO) Q2 Revenue Rises 1%

Exponent (EXPO) Q2 Revenue Rises 1%

EXPO

seekingalpha.com

Exponent, Inc. (EXPO) Q2 2025 Earnings Call Transcript

Exponent, Inc. (NASDAQ:EXPO ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Catherine Ford Corrigan - President, CEO & Director Richard L. Schlenker - Executive VP, CFO & Corporate Secretary Conference Call Participants Karandeep Singhania - UBS Investment Bank, Research Division Tyler David Barishaw - Truist Securities, Inc., Research Division Joni Konstantelos - Unidentified Company Operator Good day, and welcome to Exponent Second Quarter 2025 Earnings Conference Call.

EXPO

zacks.com

Exponent (EXPO) Q2 Earnings and Revenues Top Estimates

Exponent (EXPO) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.57 per share a year ago.

EXPO

seekingalpha.com

Exponent, Inc. (EXPO) Q1 2025 Earnings Conference Call Transcript

Exponent, Inc. (NASDAQ:EXPO ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting, IR Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Josh Chan - UBS Operator Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode.

EXPO

businesswire.com

Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25.

EXPO

seekingalpha.com

Exponent: A Unique Dividend Contender That Is Valued At A Premium

Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener